

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.12873119 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.12873119 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.77214378 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.77214378 |
| 5 | glutamate secretion (GO:0014047) | 4.58571390 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 4.45390154 |
| 7 | gamma-aminobutyric acid transport (GO:0015812) | 4.14589593 |
| 8 | bile acid biosynthetic process (GO:0006699) | 4.07312455 |
| 9 | protein K11-linked deubiquitination (GO:0035871) | 4.04134312 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.00572812 |
| 11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.00454352 |
| 12 | kynurenine metabolic process (GO:0070189) | 3.94318325 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 3.89587476 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 3.89587476 |
| 15 | tryptophan catabolic process (GO:0006569) | 3.89587476 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.88143201 |
| 17 | vocalization behavior (GO:0071625) | 3.77869836 |
| 18 | neurotransmitter secretion (GO:0007269) | 3.77495922 |
| 19 | glutamate metabolic process (GO:0006536) | 3.74937035 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.74498914 |
| 21 | urea metabolic process (GO:0019627) | 3.72688500 |
| 22 | urea cycle (GO:0000050) | 3.72688500 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.68846925 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 3.68745573 |
| 25 | righting reflex (GO:0060013) | 3.67876789 |
| 26 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.66145639 |
| 27 | regulation of fibrinolysis (GO:0051917) | 3.64528463 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 3.64079912 |
| 29 | regulation of protein activation cascade (GO:2000257) | 3.63321662 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 3.63063858 |
| 31 | tryptophan metabolic process (GO:0006568) | 3.61300595 |
| 32 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.60539380 |
| 33 | complement activation, alternative pathway (GO:0006957) | 3.60463500 |
| 34 | neuron cell-cell adhesion (GO:0007158) | 3.60337876 |
| 35 | high-density lipoprotein particle remodeling (GO:0034375) | 3.58280633 |
| 36 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.56202843 |
| 37 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.55619631 |
| 38 | synaptic vesicle maturation (GO:0016188) | 3.55003411 |
| 39 | startle response (GO:0001964) | 3.51306288 |
| 40 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.49078610 |
| 41 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.48832478 |
| 42 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.47771893 |
| 43 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.47478910 |
| 44 | coenzyme catabolic process (GO:0009109) | 3.47374100 |
| 45 | dopamine biosynthetic process (GO:0042416) | 3.45497705 |
| 46 | tyrosine metabolic process (GO:0006570) | 3.43600885 |
| 47 | bile acid metabolic process (GO:0008206) | 3.40892408 |
| 48 | glyoxylate metabolic process (GO:0046487) | 3.38931198 |
| 49 | nitrogen cycle metabolic process (GO:0071941) | 3.37251128 |
| 50 | regulation of complement activation (GO:0030449) | 3.36350181 |
| 51 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.36088768 |
| 52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.34879269 |
| 53 | protein carboxylation (GO:0018214) | 3.34136417 |
| 54 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.34136417 |
| 55 | locomotory exploration behavior (GO:0035641) | 3.34070726 |
| 56 | dendritic spine morphogenesis (GO:0060997) | 3.33122803 |
| 57 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.32476338 |
| 58 | regulation of ARF protein signal transduction (GO:0032012) | 3.32142254 |
| 59 | protein localization to synapse (GO:0035418) | 3.27873803 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 3.26013002 |
| 61 | establishment of nucleus localization (GO:0040023) | 3.25151627 |
| 62 | neuronal action potential propagation (GO:0019227) | 3.23959674 |
| 63 | central nervous system neuron axonogenesis (GO:0021955) | 3.23526299 |
| 64 | cysteine metabolic process (GO:0006534) | 3.23237295 |
| 65 | glutamate receptor signaling pathway (GO:0007215) | 3.20819675 |
| 66 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.16105725 |
| 67 | presynaptic membrane organization (GO:0097090) | 3.15798862 |
| 68 | regulation of Rac protein signal transduction (GO:0035020) | 3.15411348 |
| 69 | regulation of synaptic vesicle transport (GO:1902803) | 3.15224838 |
| 70 | nucleobase catabolic process (GO:0046113) | 3.12741058 |
| 71 | ketone body metabolic process (GO:1902224) | 3.12726872 |
| 72 | establishment of protein localization to Golgi (GO:0072600) | 3.10458398 |
| 73 | auditory behavior (GO:0031223) | 3.10375391 |
| 74 | reverse cholesterol transport (GO:0043691) | 3.10043189 |
| 75 | triglyceride homeostasis (GO:0070328) | 3.09313834 |
| 76 | acylglycerol homeostasis (GO:0055090) | 3.09313834 |
| 77 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.09202264 |
| 78 | axonal fasciculation (GO:0007413) | 3.08130301 |
| 79 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.07619277 |
| 80 | bile acid and bile salt transport (GO:0015721) | 3.04053806 |
| 81 | sulfur amino acid catabolic process (GO:0000098) | 3.02750914 |
| 82 | plasma lipoprotein particle remodeling (GO:0034369) | 3.01520445 |
| 83 | protein-lipid complex remodeling (GO:0034368) | 3.01520445 |
| 84 | macromolecular complex remodeling (GO:0034367) | 3.01520445 |
| 85 | alpha-amino acid catabolic process (GO:1901606) | 3.01080530 |
| 86 | negative regulation of neurotransmitter transport (GO:0051589) | 3.01022397 |
| 87 | neurotransmitter transport (GO:0006836) | 3.00462903 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 2.99535775 |
| 89 | indolalkylamine metabolic process (GO:0006586) | 2.98134719 |
| 90 | alkaloid metabolic process (GO:0009820) | 2.95399151 |
| 91 | regulation of neurotransmitter levels (GO:0001505) | 2.94689866 |
| 92 | synaptic transmission, glutamatergic (GO:0035249) | 2.94483345 |
| 93 | behavioral response to cocaine (GO:0048148) | 2.93116360 |
| 94 | serine family amino acid catabolic process (GO:0009071) | 2.92914484 |
| 95 | histone H3-K4 trimethylation (GO:0080182) | 2.90875377 |
| 96 | lysine catabolic process (GO:0006554) | 2.90860289 |
| 97 | lysine metabolic process (GO:0006553) | 2.90860289 |
| 98 | insulin secretion (GO:0030073) | 2.90578788 |
| 99 | dicarboxylic acid catabolic process (GO:0043649) | 2.89777492 |
| 100 | protein targeting to Golgi (GO:0000042) | 2.86828677 |
| 101 | regulation of cholesterol esterification (GO:0010872) | 2.86583864 |
| 102 | neuron recognition (GO:0008038) | 2.85782003 |
| 103 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.85488303 |
| 104 | phospholipid efflux (GO:0033700) | 2.82637381 |
| 105 | cellular modified amino acid catabolic process (GO:0042219) | 2.80535724 |
| 106 | neural tube formation (GO:0001841) | 2.80376681 |
| 107 | cholesterol efflux (GO:0033344) | 2.80332069 |
| 108 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.80234895 |
| 109 | negative regulation of sterol transport (GO:0032372) | 2.79704992 |
| 110 | negative regulation of cholesterol transport (GO:0032375) | 2.79704992 |
| 111 | negative regulation of protein activation cascade (GO:2000258) | 2.78515577 |
| 112 | cellular amino acid catabolic process (GO:0009063) | 2.78123568 |
| 113 | cell differentiation in hindbrain (GO:0021533) | 2.78120933 |
| 114 | regulation of triglyceride catabolic process (GO:0010896) | 2.77967669 |
| 115 | cerebellar granule cell differentiation (GO:0021707) | 2.77333534 |
| 116 | detection of calcium ion (GO:0005513) | 2.76224834 |
| 117 | homocysteine metabolic process (GO:0050667) | 2.75245476 |
| 118 | atrial cardiac muscle cell action potential (GO:0086014) | 2.74670254 |
| 119 | ethanol oxidation (GO:0006069) | 2.74384047 |
| 120 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.73609780 |
| 121 | serotonin metabolic process (GO:0042428) | 2.73527214 |
| 122 | layer formation in cerebral cortex (GO:0021819) | 2.73036818 |
| 123 | cytolysis (GO:0019835) | 2.72622534 |
| 124 | postsynaptic membrane organization (GO:0001941) | 2.71048179 |
| 125 | cellular response to ethanol (GO:0071361) | 2.69687655 |
| 126 | membrane depolarization during action potential (GO:0086010) | 2.68984324 |
| 127 | presynaptic membrane assembly (GO:0097105) | 2.68332445 |
| 128 | activated T cell proliferation (GO:0050798) | 2.67312584 |
| 129 | drug catabolic process (GO:0042737) | 2.66803125 |
| 130 | benzene-containing compound metabolic process (GO:0042537) | 2.66713974 |
| 131 | exploration behavior (GO:0035640) | 2.65760096 |
| 132 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.65012748 |
| 133 | nerve growth factor signaling pathway (GO:0038180) | 2.63826162 |
| 134 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.63740436 |
| 135 | endocrine pancreas development (GO:0031018) | 2.63640012 |
| 136 | neuron-neuron synaptic transmission (GO:0007270) | 2.62952468 |
| 137 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.62661762 |
| 138 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.62515212 |
| 139 | prepulse inhibition (GO:0060134) | 2.61773777 |
| 140 | catecholamine transport (GO:0051937) | 2.61043029 |
| 141 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.60767390 |
| 142 | regulation of postsynaptic membrane potential (GO:0060078) | 2.60516820 |
| 143 | regulation of bile acid biosynthetic process (GO:0070857) | 2.59796099 |
| 144 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.59343214 |
| 145 | indole-containing compound metabolic process (GO:0042430) | 2.58534082 |
| 146 | mechanosensory behavior (GO:0007638) | 2.57216412 |
| 147 | negative regulation of dendrite development (GO:2000171) | 2.56584928 |
| 148 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.56134792 |
| 149 | protein K48-linked deubiquitination (GO:0071108) | 2.56121194 |
| 150 | long-term synaptic potentiation (GO:0060291) | 2.55658745 |
| 151 | inositol phosphate catabolic process (GO:0071545) | 2.55279961 |
| 152 | phospholipid translocation (GO:0045332) | 2.54834583 |
| 153 | lipid translocation (GO:0034204) | 2.54834583 |
| 154 | cellular response to interleukin-15 (GO:0071350) | 2.53722596 |
| 155 | regulation of neurotransmitter secretion (GO:0046928) | 2.51658078 |
| 156 | macroautophagy (GO:0016236) | 2.50640070 |
| 157 | dendrite morphogenesis (GO:0048813) | 2.50255650 |
| 158 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.49432424 |
| 159 | regulation of respiratory gaseous exchange (GO:0043576) | 2.48961488 |
| 160 | regulation of glucokinase activity (GO:0033131) | 2.48861485 |
| 161 | regulation of hexokinase activity (GO:1903299) | 2.48861485 |
| 162 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.48413626 |
| 163 | primary amino compound metabolic process (GO:1901160) | 2.47334530 |
| 164 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.46490662 |
| 165 | early endosome to late endosome transport (GO:0045022) | 2.46102673 |
| 166 | reflex (GO:0060004) | 2.45350394 |
| 167 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.42920465 |
| 168 | chemosensory behavior (GO:0007635) | 2.42396876 |
| 169 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.40234425 |
| 170 | regulation of neurotransmitter transport (GO:0051588) | 2.40031501 |
| 171 | regulation of energy homeostasis (GO:2000505) | 2.38818693 |
| 172 | positive regulation of neurotransmitter transport (GO:0051590) | 2.38642343 |
| 173 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.38157809 |
| 174 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.38157809 |
| 175 | neuron maturation (GO:0042551) | 2.37498927 |
| 176 | proline transport (GO:0015824) | 2.36252474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.00549438 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.54095408 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.50642407 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.31469740 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.05656619 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.88623163 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.79231806 |
| 8 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.68494309 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.47641102 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.45988460 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.44898977 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.42518635 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.39502547 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.31683658 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.25538798 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.17718779 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.15241639 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.14930174 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.11473650 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.03515588 |
| 21 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.02873616 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.99306853 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.93686896 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92899652 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90166872 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.87306413 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.85621109 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.85621109 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.84254856 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.82506388 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.81718729 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.79498572 |
| 33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.78082685 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.73468876 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73276903 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69676305 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.68628044 |
| 38 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.65501791 |
| 39 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.62845017 |
| 40 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.61296477 |
| 41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.58717787 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57795690 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.54803191 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.54705034 |
| 45 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.52770050 |
| 46 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.52639818 |
| 47 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51416853 |
| 48 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.51006610 |
| 49 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.49812374 |
| 50 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.49787728 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48376297 |
| 52 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.45277317 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41584432 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39882345 |
| 55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38674012 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36678707 |
| 57 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.36304792 |
| 58 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.33667022 |
| 59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33365549 |
| 60 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.32982869 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32288868 |
| 62 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.31423361 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28788854 |
| 64 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.28775482 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28000168 |
| 66 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27998022 |
| 67 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.27998022 |
| 68 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27904010 |
| 69 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25643168 |
| 70 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.24559282 |
| 71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24385031 |
| 72 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.23952402 |
| 73 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22754963 |
| 74 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.22348745 |
| 75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22295507 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21126214 |
| 77 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19715264 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19519215 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19510813 |
| 80 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.19140539 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18139763 |
| 82 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17174625 |
| 83 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16939137 |
| 84 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16652059 |
| 85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16628288 |
| 86 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16625697 |
| 87 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16625697 |
| 88 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.14208782 |
| 89 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14102951 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12690894 |
| 91 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12076487 |
| 92 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11840429 |
| 93 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10463041 |
| 94 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.09949897 |
| 95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09723255 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09640526 |
| 97 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08891904 |
| 98 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08742261 |
| 99 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08515443 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07896105 |
| 101 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07176830 |
| 102 | AR_19668381_ChIP-Seq_PC3_Human | 1.05825771 |
| 103 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.05773834 |
| 104 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.04550505 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04192459 |
| 106 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03391042 |
| 107 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.02715188 |
| 108 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02216462 |
| 109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01242540 |
| 110 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.01145426 |
| 111 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01057338 |
| 112 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00649982 |
| 113 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00570222 |
| 114 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99898026 |
| 115 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99576754 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99054667 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99011205 |
| 118 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98577360 |
| 119 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98473306 |
| 120 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95924333 |
| 121 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.95244875 |
| 122 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94844457 |
| 123 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.94052705 |
| 124 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92828269 |
| 125 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91929055 |
| 126 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90734587 |
| 127 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89714468 |
| 128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89390963 |
| 129 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.88683502 |
| 130 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88568259 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88370203 |
| 132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88370203 |
| 133 | KDM2B_26808549_Chip-Seq_REH_Human | 0.85357360 |
| 134 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85292823 |
| 135 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.85028577 |
| 136 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84058967 |
| 137 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83244073 |
| 138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81291207 |
| 139 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80554464 |
| 140 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80239897 |
| 141 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79912267 |
| 142 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.79451376 |
| 143 | TP53_16413492_ChIP-PET_HCT116_Human | 0.78634319 |
| 144 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.78323145 |
| 145 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.76718670 |
| 146 | RXR_22108803_ChIP-Seq_LS180_Human | 0.75801168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.05838278 |
| 2 | MP0005360_urolithiasis | 4.72240131 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.13843491 |
| 4 | MP0005365_abnormal_bile_salt | 4.02077184 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.70375397 |
| 6 | MP0003880_abnormal_central_pattern | 3.66300090 |
| 7 | MP0003787_abnormal_imprinting | 3.49143754 |
| 8 | MP0000569_abnormal_digit_pigmentation | 3.45513565 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.32509394 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.82484774 |
| 11 | MP0008057_abnormal_DNA_replication | 2.56320289 |
| 12 | MP0009046_muscle_twitch | 2.50975967 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.45029475 |
| 14 | MP0004270_analgesia | 2.43749750 |
| 15 | MP0003252_abnormal_bile_duct | 2.43263345 |
| 16 | MP0009745_abnormal_behavioral_response | 2.39753251 |
| 17 | MP0002064_seizures | 2.29483017 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.22196446 |
| 19 | MP0005083_abnormal_biliary_tract | 2.21785646 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.15963765 |
| 21 | MP0003329_amyloid_beta_deposits | 2.09032267 |
| 22 | MP0008877_abnormal_DNA_methylation | 2.04565253 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.95666587 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 1.94511535 |
| 25 | MP0003195_calcinosis | 1.92835190 |
| 26 | MP0002163_abnormal_gland_morphology | 1.92223132 |
| 27 | MP0005423_abnormal_somatic_nervous | 1.92046023 |
| 28 | MP0003868_abnormal_feces_composition | 1.87199334 |
| 29 | MP0002734_abnormal_mechanical_nocicepti | 1.80116046 |
| 30 | MP0002272_abnormal_nervous_system | 1.77213835 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.73650856 |
| 32 | MP0002928_abnormal_bile_duct | 1.70145027 |
| 33 | MP0002822_catalepsy | 1.69566528 |
| 34 | MP0001188_hyperpigmentation | 1.68862206 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.68156234 |
| 36 | MP0005379_endocrine/exocrine_gland_phen | 1.64930693 |
| 37 | MP0002735_abnormal_chemical_nociception | 1.64153022 |
| 38 | MP0001486_abnormal_startle_reflex | 1.62952179 |
| 39 | MP0002736_abnormal_nociception_after | 1.62257486 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.61925673 |
| 41 | MP0000427_abnormal_hair_cycle | 1.61778624 |
| 42 | MP0005332_abnormal_amino_acid | 1.60916609 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.59637187 |
| 44 | MP0002638_abnormal_pupillary_reflex | 1.58973250 |
| 45 | MP0000604_amyloidosis | 1.55316771 |
| 46 | MP0001440_abnormal_grooming_behavior | 1.54180350 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.50840998 |
| 48 | MP0005248_abnormal_Harderian_gland | 1.50489955 |
| 49 | MP0003890_abnormal_embryonic-extraembry | 1.49083626 |
| 50 | MP0002733_abnormal_thermal_nociception | 1.48878645 |
| 51 | MP0001944_abnormal_pancreas_morphology | 1.47747689 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.47186768 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.45661127 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.44511180 |
| 55 | MP0005386_behavior/neurological_phenoty | 1.42941964 |
| 56 | MP0004924_abnormal_behavior | 1.42941964 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.41927535 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.41918506 |
| 59 | MP0002693_abnormal_pancreas_physiology | 1.41167341 |
| 60 | MP0003122_maternal_imprinting | 1.39719558 |
| 61 | MP0003121_genomic_imprinting | 1.37815563 |
| 62 | MP0005535_abnormal_body_temperature | 1.32176843 |
| 63 | MP0003879_abnormal_hair_cell | 1.23713471 |
| 64 | MP0001970_abnormal_pain_threshold | 1.23338246 |
| 65 | MP0002557_abnormal_social/conspecific_i | 1.22111409 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.21888291 |
| 67 | MP0002009_preneoplasia | 1.20906761 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 1.19942425 |
| 69 | MP0008872_abnormal_physiological_respon | 1.19869064 |
| 70 | MP0001502_abnormal_circadian_rhythm | 1.19420472 |
| 71 | MP0009840_abnormal_foam_cell | 1.18182393 |
| 72 | MP0000609_abnormal_liver_physiology | 1.17137948 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 1.16825363 |
| 74 | MP0003633_abnormal_nervous_system | 1.16607214 |
| 75 | MP0008569_lethality_at_weaning | 1.16237448 |
| 76 | MP0002876_abnormal_thyroid_physiology | 1.16174394 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 1.14679480 |
| 78 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13007594 |
| 79 | MP0002184_abnormal_innervation | 1.12720181 |
| 80 | MP0010678_abnormal_skin_adnexa | 1.10815789 |
| 81 | MP0001984_abnormal_olfaction | 1.09304265 |
| 82 | MP0005646_abnormal_pituitary_gland | 1.08753657 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 1.08394644 |
| 84 | MP0004811_abnormal_neuron_physiology | 1.01002797 |
| 85 | MP0008874_decreased_physiological_sensi | 1.00923168 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.99059158 |
| 87 | MP0003045_fibrosis | 0.98157821 |
| 88 | MP0004142_abnormal_muscle_tone | 0.97764087 |
| 89 | MP0003631_nervous_system_phenotype | 0.97190325 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 0.96865156 |
| 91 | MP0002066_abnormal_motor_capabilities/c | 0.96725748 |
| 92 | MP0001905_abnormal_dopamine_level | 0.96165465 |
| 93 | MP0000631_abnormal_neuroendocrine_gland | 0.95989342 |
| 94 | MP0000955_abnormal_spinal_cord | 0.94539266 |
| 95 | MP0005174_abnormal_tail_pigmentation | 0.91487460 |
| 96 | MP0010234_abnormal_vibrissa_follicle | 0.91207173 |
| 97 | MP0001764_abnormal_homeostasis | 0.89737647 |
| 98 | MP0002090_abnormal_vision | 0.89277105 |
| 99 | MP0000778_abnormal_nervous_system | 0.88055318 |
| 100 | MP0002229_neurodegeneration | 0.87981259 |
| 101 | MP0008961_abnormal_basal_metabolism | 0.86155365 |
| 102 | MP0002078_abnormal_glucose_homeostasis | 0.85936717 |
| 103 | MP0005253_abnormal_eye_physiology | 0.85849936 |
| 104 | MP0004858_abnormal_nervous_system | 0.84215409 |
| 105 | MP0003690_abnormal_glial_cell | 0.83486588 |
| 106 | MP0000639_abnormal_adrenal_gland | 0.83414896 |
| 107 | MP0000013_abnormal_adipose_tissue | 0.82662537 |
| 108 | MP0003011_delayed_dark_adaptation | 0.82048951 |
| 109 | MP0004130_abnormal_muscle_cell | 0.81599508 |
| 110 | MP0002277_abnormal_respiratory_mucosa | 0.81476706 |
| 111 | MP0002069_abnormal_eating/drinking_beha | 0.79496266 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.78711799 |
| 113 | MP0002882_abnormal_neuron_morphology | 0.77559544 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.77417951 |
| 115 | MP0004885_abnormal_endolymph | 0.76923950 |
| 116 | MP0001919_abnormal_reproductive_system | 0.76431863 |
| 117 | MP0003632_abnormal_nervous_system | 0.74953867 |
| 118 | MP0005448_abnormal_energy_balance | 0.74454331 |
| 119 | MP0003283_abnormal_digestive_organ | 0.72119027 |
| 120 | MP0000015_abnormal_ear_pigmentation | 0.70256393 |
| 121 | MP0003300_gastrointestinal_ulcer | 0.70161303 |
| 122 | MP0005220_abnormal_exocrine_pancreas | 0.67773188 |
| 123 | MP0004043_abnormal_pH_regulation | 0.67688299 |
| 124 | MP0003866_abnormal_defecation | 0.67449633 |
| 125 | MP0002082_postnatal_lethality | 0.67096233 |
| 126 | MP0010770_preweaning_lethality | 0.67096233 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.65528067 |
| 128 | MP0001529_abnormal_vocalization | 0.62557127 |
| 129 | MP0001177_atelectasis | 0.60855198 |
| 130 | MP0006035_abnormal_mitochondrial_morpho | 0.59524542 |
| 131 | MP0003953_abnormal_hormone_level | 0.56143172 |
| 132 | MP0005187_abnormal_penis_morphology | 0.55936918 |
| 133 | MP0004742_abnormal_vestibular_system | 0.52390410 |
| 134 | MP0003638_abnormal_response/metabolism_ | 0.52287408 |
| 135 | MP0002152_abnormal_brain_morphology | 0.51923634 |
| 136 | MP0005334_abnormal_fat_pad | 0.51072370 |
| 137 | MP0002254_reproductive_system_inflammat | 0.51061201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.16803638 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.12996395 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.87324626 |
| 4 | Focal motor seizures (HP:0011153) | 4.83232936 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.53077162 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.20906167 |
| 7 | Hyperventilation (HP:0002883) | 4.20458108 |
| 8 | Xanthomatosis (HP:0000991) | 4.11499969 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.06830789 |
| 10 | Complement deficiency (HP:0004431) | 4.00158122 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 3.81378632 |
| 12 | Focal seizures (HP:0007359) | 3.63016364 |
| 13 | Visual hallucinations (HP:0002367) | 3.60003107 |
| 14 | Epileptic encephalopathy (HP:0200134) | 3.54160240 |
| 15 | Atonic seizures (HP:0010819) | 3.39709070 |
| 16 | Myokymia (HP:0002411) | 3.31145034 |
| 17 | Epidermoid cyst (HP:0200040) | 3.30302173 |
| 18 | Status epilepticus (HP:0002133) | 3.28516211 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.19567597 |
| 20 | Ketosis (HP:0001946) | 3.15238149 |
| 21 | Absence seizures (HP:0002121) | 3.06539932 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 3.01184730 |
| 23 | Conjugated hyperbilirubinemia (HP:0002908) | 2.99950086 |
| 24 | Hypolipoproteinemia (HP:0010981) | 2.96790481 |
| 25 | Hypothermia (HP:0002045) | 2.89793457 |
| 26 | Generalized tonic-clonic seizures (HP:0002069) | 2.87763160 |
| 27 | Joint hemorrhage (HP:0005261) | 2.86581786 |
| 28 | Limb dystonia (HP:0002451) | 2.85262158 |
| 29 | Febrile seizures (HP:0002373) | 2.83704982 |
| 30 | Hyperglycinemia (HP:0002154) | 2.80782533 |
| 31 | Genetic anticipation (HP:0003743) | 2.71338278 |
| 32 | Impaired social interactions (HP:0000735) | 2.69210499 |
| 33 | Abnormal social behavior (HP:0012433) | 2.69210499 |
| 34 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.68165872 |
| 35 | Dialeptic seizures (HP:0011146) | 2.68116785 |
| 36 | Fat malabsorption (HP:0002630) | 2.67905525 |
| 37 | Volvulus (HP:0002580) | 2.65480085 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.65122046 |
| 39 | Abnormality of complement system (HP:0005339) | 2.64656623 |
| 40 | Poor eye contact (HP:0000817) | 2.61532459 |
| 41 | Hyperammonemia (HP:0001987) | 2.61532405 |
| 42 | Protruding tongue (HP:0010808) | 2.60268807 |
| 43 | Ketoacidosis (HP:0001993) | 2.56247008 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.52258525 |
| 45 | Hypoalphalipoproteinemia (HP:0003233) | 2.50560168 |
| 46 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.48987396 |
| 47 | Epileptiform EEG discharges (HP:0011182) | 2.48701356 |
| 48 | Dysdiadochokinesis (HP:0002075) | 2.48642515 |
| 49 | Cerebral inclusion bodies (HP:0100314) | 2.47038391 |
| 50 | Widely spaced teeth (HP:0000687) | 2.46746927 |
| 51 | Absent speech (HP:0001344) | 2.45501818 |
| 52 | EEG with generalized epileptiform discharges (HP:0011198) | 2.44568933 |
| 53 | Action tremor (HP:0002345) | 2.44502735 |
| 54 | Chronic hepatic failure (HP:0100626) | 2.44035708 |
| 55 | Menstrual irregularities (HP:0000858) | 2.43898720 |
| 56 | Papillary thyroid carcinoma (HP:0002895) | 2.43722173 |
| 57 | Abnormality of methionine metabolism (HP:0010901) | 2.43627296 |
| 58 | Scanning speech (HP:0002168) | 2.43446733 |
| 59 | Abnormal gallbladder physiology (HP:0012438) | 2.42856121 |
| 60 | Cholecystitis (HP:0001082) | 2.42856121 |
| 61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.42667226 |
| 62 | Papilledema (HP:0001085) | 2.39053073 |
| 63 | Fair hair (HP:0002286) | 2.38460257 |
| 64 | Abnormality of the lower motor neuron (HP:0002366) | 2.38170041 |
| 65 | Abnormality of the intrinsic pathway (HP:0010989) | 2.38069545 |
| 66 | Hypsarrhythmia (HP:0002521) | 2.36520532 |
| 67 | Pheochromocytoma (HP:0002666) | 2.36484769 |
| 68 | Spontaneous abortion (HP:0005268) | 2.35713202 |
| 69 | Gaze-evoked nystagmus (HP:0000640) | 2.34881048 |
| 70 | Excessive salivation (HP:0003781) | 2.34253277 |
| 71 | Drooling (HP:0002307) | 2.34253277 |
| 72 | Neonatal onset (HP:0003623) | 2.33348733 |
| 73 | Broad-based gait (HP:0002136) | 2.32848403 |
| 74 | Short chin (HP:0000331) | 2.32599309 |
| 75 | Stomach cancer (HP:0012126) | 2.31603173 |
| 76 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.31034220 |
| 77 | Neoplasm of the adrenal cortex (HP:0100641) | 2.30951796 |
| 78 | Skin nodule (HP:0200036) | 2.30770256 |
| 79 | Abnormal pancreas size (HP:0012094) | 2.28769328 |
| 80 | Subacute progressive viral hepatitis (HP:0006572) | 2.28543625 |
| 81 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.25608228 |
| 82 | Neurofibrillary tangles (HP:0002185) | 2.25447380 |
| 83 | Supranuclear gaze palsy (HP:0000605) | 2.21914291 |
| 84 | Hypochromic microcytic anemia (HP:0004840) | 2.21773159 |
| 85 | Blue irides (HP:0000635) | 2.21372301 |
| 86 | Generalized myoclonic seizures (HP:0002123) | 2.19606505 |
| 87 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.19410529 |
| 88 | Torticollis (HP:0000473) | 2.17387345 |
| 89 | Increased CSF protein (HP:0002922) | 2.16278543 |
| 90 | Hypoglycemic coma (HP:0001325) | 2.15582894 |
| 91 | Hemiparesis (HP:0001269) | 2.14295639 |
| 92 | Gout (HP:0001997) | 2.14013794 |
| 93 | Impaired smooth pursuit (HP:0007772) | 2.13942335 |
| 94 | Hyperbilirubinemia (HP:0002904) | 2.13076605 |
| 95 | Sensorimotor neuropathy (HP:0007141) | 2.13034976 |
| 96 | Hypercholesterolemia (HP:0003124) | 2.12114419 |
| 97 | Amyotrophic lateral sclerosis (HP:0007354) | 2.10813787 |
| 98 | Truncal obesity (HP:0001956) | 2.10192409 |
| 99 | Spastic gait (HP:0002064) | 2.10036053 |
| 100 | Lissencephaly (HP:0001339) | 2.09466139 |
| 101 | Dysmetria (HP:0001310) | 2.09025775 |
| 102 | Generalized hypopigmentation of hair (HP:0011358) | 2.08921138 |
| 103 | Dyskinesia (HP:0100660) | 2.08848985 |
| 104 | Aqueductal stenosis (HP:0002410) | 2.08841352 |
| 105 | Tetraplegia (HP:0002445) | 2.07720850 |
| 106 | Abnormality of glycine metabolism (HP:0010895) | 2.07440448 |
| 107 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.07440448 |
| 108 | Abnormality of the corticospinal tract (HP:0002492) | 2.06515190 |
| 109 | Mitral stenosis (HP:0001718) | 2.06465364 |
| 110 | Intention tremor (HP:0002080) | 2.06034596 |
| 111 | Anxiety (HP:0000739) | 2.04052881 |
| 112 | Abnormal gallbladder morphology (HP:0012437) | 2.04022731 |
| 113 | Impaired vibratory sensation (HP:0002495) | 2.02794954 |
| 114 | Truncal ataxia (HP:0002078) | 2.02426046 |
| 115 | Focal dystonia (HP:0004373) | 2.02206010 |
| 116 | Diplopia (HP:0000651) | 2.01670168 |
| 117 | Abnormality of binocular vision (HP:0011514) | 2.01670168 |
| 118 | Neuroendocrine neoplasm (HP:0100634) | 2.01131330 |
| 119 | Dysmetric saccades (HP:0000641) | 2.00864251 |
| 120 | Curly hair (HP:0002212) | 2.00792827 |
| 121 | Craniofacial dystonia (HP:0012179) | 2.00214052 |
| 122 | Postural instability (HP:0002172) | 1.99095127 |
| 123 | Depression (HP:0000716) | 1.99041671 |
| 124 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.98954847 |
| 125 | Acanthocytosis (HP:0001927) | 1.98719005 |
| 126 | Agitation (HP:0000713) | 1.98179487 |
| 127 | Progressive inability to walk (HP:0002505) | 1.95716107 |
| 128 | Cholelithiasis (HP:0001081) | 1.95327632 |
| 129 | Tented upper lip vermilion (HP:0010804) | 1.94488880 |
| 130 | Insidious onset (HP:0003587) | 1.94023000 |
| 131 | Termporal pattern (HP:0011008) | 1.94023000 |
| 132 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93280557 |
| 133 | Thickened helices (HP:0000391) | 1.93224037 |
| 134 | Macroorchidism (HP:0000053) | 1.91581905 |
| 135 | Muscular hypotonia of the trunk (HP:0008936) | 1.91268004 |
| 136 | Inability to walk (HP:0002540) | 1.89796079 |
| 137 | Thyroid carcinoma (HP:0002890) | 1.87651886 |
| 138 | Hepatoblastoma (HP:0002884) | 1.86286873 |
| 139 | Oligodactyly (hands) (HP:0001180) | 1.84923332 |
| 140 | Open mouth (HP:0000194) | 1.83674945 |
| 141 | Tapered finger (HP:0001182) | 1.77935711 |
| 142 | T lymphocytopenia (HP:0005403) | 1.77892065 |
| 143 | Abnormality of the renal cortex (HP:0011035) | 1.76160955 |
| 144 | Abnormality of salivation (HP:0100755) | 1.76130316 |
| 145 | Akinesia (HP:0002304) | 1.75755082 |
| 146 | Gastroesophageal reflux (HP:0002020) | 1.75682429 |
| 147 | Heterotopia (HP:0002282) | 1.74166856 |
| 148 | Increased density of long bones (HP:0006392) | 1.73620336 |
| 149 | Stomatitis (HP:0010280) | 1.71654302 |
| 150 | Renal cortical cysts (HP:0000803) | 1.70979007 |
| 151 | Intellectual disability, progressive (HP:0006887) | 1.69842737 |
| 152 | Abnormality of T cell number (HP:0011839) | 1.68586454 |
| 153 | Exotropia (HP:0000577) | 1.68183363 |
| 154 | Gait imbalance (HP:0002141) | 1.68147121 |
| 155 | Abnormal eating behavior (HP:0100738) | 1.67184958 |
| 156 | Late onset (HP:0003584) | 1.66974537 |
| 157 | Postural tremor (HP:0002174) | 1.66543450 |
| 158 | Intestinal atresia (HP:0011100) | 1.65801575 |
| 159 | Hamartoma of the eye (HP:0010568) | 1.64549689 |
| 160 | Large for gestational age (HP:0001520) | 1.64437216 |
| 161 | Thyroiditis (HP:0100646) | 1.62445273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.44595479 |
| 2 | MAP3K9 | 3.44026344 |
| 3 | MAP3K4 | 3.33367213 |
| 4 | DAPK2 | 3.26530130 |
| 5 | MARK1 | 3.15513601 |
| 6 | MAP2K4 | 3.12592608 |
| 7 | NTRK3 | 2.87965550 |
| 8 | EPHA4 | 2.76380510 |
| 9 | MAP2K7 | 2.72927363 |
| 10 | MAP3K12 | 2.40943840 |
| 11 | TNIK | 2.22512685 |
| 12 | MINK1 | 2.21018396 |
| 13 | NLK | 1.86684992 |
| 14 | PAK6 | 1.81440304 |
| 15 | NTRK2 | 1.69720422 |
| 16 | EPHA3 | 1.69014045 |
| 17 | NTRK1 | 1.66004307 |
| 18 | CAMKK1 | 1.63333446 |
| 19 | GRK5 | 1.57589539 |
| 20 | FGFR3 | 1.53759582 |
| 21 | KSR2 | 1.49478290 |
| 22 | BRD4 | 1.47579682 |
| 23 | CAMKK2 | 1.47256045 |
| 24 | CDK19 | 1.46785257 |
| 25 | DAPK1 | 1.45557408 |
| 26 | ERBB4 | 1.44021587 |
| 27 | SIK2 | 1.41886898 |
| 28 | INSRR | 1.38125170 |
| 29 | TXK | 1.36256815 |
| 30 | CSNK1G2 | 1.29014050 |
| 31 | PLK2 | 1.27907795 |
| 32 | RET | 1.24723433 |
| 33 | PNCK | 1.24125422 |
| 34 | CDK5 | 1.20431979 |
| 35 | PRKCG | 1.19914463 |
| 36 | MAP3K2 | 1.19801294 |
| 37 | FRK | 1.18017496 |
| 38 | ERBB3 | 1.13935415 |
| 39 | PASK | 1.08157794 |
| 40 | LATS2 | 1.08154182 |
| 41 | STK38 | 1.07793618 |
| 42 | MAP3K13 | 1.05902138 |
| 43 | FGFR4 | 1.05703353 |
| 44 | TAOK3 | 1.05144181 |
| 45 | SGK2 | 1.02132751 |
| 46 | WNK1 | 1.02087924 |
| 47 | FGFR2 | 1.00700794 |
| 48 | KSR1 | 0.99074734 |
| 49 | CDK12 | 0.98847319 |
| 50 | SGK494 | 0.98184891 |
| 51 | SGK223 | 0.98184891 |
| 52 | CCNB1 | 0.98178004 |
| 53 | CAMK2A | 0.96175696 |
| 54 | STK11 | 0.95054151 |
| 55 | PRKCH | 0.94768314 |
| 56 | MAPK13 | 0.94290748 |
| 57 | SGK3 | 0.91767979 |
| 58 | AKT3 | 0.89776625 |
| 59 | BCKDK | 0.89145880 |
| 60 | SIK1 | 0.87482811 |
| 61 | BCR | 0.85901652 |
| 62 | MAPK12 | 0.85171381 |
| 63 | PAK3 | 0.81871105 |
| 64 | PHKG1 | 0.81833957 |
| 65 | PHKG2 | 0.81833957 |
| 66 | GRK6 | 0.81520239 |
| 67 | ITK | 0.80447358 |
| 68 | GRK1 | 0.79630970 |
| 69 | MAP3K7 | 0.77656789 |
| 70 | PRKCZ | 0.76902404 |
| 71 | MST4 | 0.76479115 |
| 72 | CDK3 | 0.76088633 |
| 73 | OXSR1 | 0.74329887 |
| 74 | CAMK2G | 0.73015220 |
| 75 | EIF2AK3 | 0.72993681 |
| 76 | MAP3K1 | 0.72155522 |
| 77 | TYRO3 | 0.71944332 |
| 78 | STK39 | 0.71646865 |
| 79 | CAMK2B | 0.69220744 |
| 80 | CAMK1G | 0.68015109 |
| 81 | FES | 0.67788295 |
| 82 | CSNK1G3 | 0.67723255 |
| 83 | ARAF | 0.66993709 |
| 84 | YES1 | 0.63957060 |
| 85 | UHMK1 | 0.63566569 |
| 86 | MAP3K6 | 0.62776029 |
| 87 | PKN1 | 0.62729359 |
| 88 | MAPK7 | 0.62587458 |
| 89 | PDK1 | 0.62548169 |
| 90 | PDPK1 | 0.61701760 |
| 91 | DYRK1A | 0.61637434 |
| 92 | HIPK2 | 0.61630778 |
| 93 | PINK1 | 0.61077421 |
| 94 | CDK15 | 0.60617299 |
| 95 | CDK18 | 0.60223644 |
| 96 | CAMK1 | 0.59694012 |
| 97 | MAP4K1 | 0.59650190 |
| 98 | TAOK1 | 0.58023849 |
| 99 | RIPK1 | 0.56991209 |
| 100 | RIPK4 | 0.56986879 |
| 101 | CHUK | 0.56150610 |
| 102 | CDK14 | 0.56117251 |
| 103 | SGK1 | 0.55812084 |
| 104 | NEK6 | 0.55603635 |
| 105 | PRKD3 | 0.51619550 |
| 106 | CDK9 | 0.51534287 |
| 107 | ACVR1B | 0.50100339 |
| 108 | LMTK2 | 0.49418715 |
| 109 | JAK2 | 0.48983985 |
| 110 | CDK11A | 0.48534002 |
| 111 | STK24 | 0.48054430 |
| 112 | SCYL2 | 0.46489758 |
| 113 | RPS6KA3 | 0.45245796 |
| 114 | CSNK1G1 | 0.45200922 |
| 115 | CSNK1D | 0.44814187 |
| 116 | CAMK4 | 0.44090683 |
| 117 | SIK3 | 0.43606737 |
| 118 | CSNK1A1L | 0.43446373 |
| 119 | FER | 0.42950016 |
| 120 | CAMK2D | 0.42398614 |
| 121 | ERN1 | 0.41689046 |
| 122 | WNK3 | 0.41411502 |
| 123 | JAK1 | 0.41128446 |
| 124 | LCK | 0.40539245 |
| 125 | MAPK4 | 0.40529471 |
| 126 | ADRBK2 | 0.40330263 |
| 127 | PRKACG | 0.40255736 |
| 128 | MAP3K5 | 0.40235908 |
| 129 | FYN | 0.40209556 |
| 130 | PRKCE | 0.40165965 |
| 131 | IRAK1 | 0.40132276 |
| 132 | DYRK3 | 0.40063028 |
| 133 | MAP3K14 | 0.39958944 |
| 134 | IRAK2 | 0.39220311 |
| 135 | MARK2 | 0.38209488 |
| 136 | IKBKE | 0.35874052 |
| 137 | TNK2 | 0.35770834 |
| 138 | PRKAA1 | 0.34744142 |
| 139 | STK38L | 0.34171369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.68686007 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.67846827 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35063244 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.71642077 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.23092586 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.11818100 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11800550 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.09652742 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.08959404 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.96913407 |
| 11 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.90072853 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.88437868 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.86439207 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 1.69102320 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.68048072 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.59749908 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.59181795 |
| 18 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.44338347 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.43838606 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41976236 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.39726277 |
| 22 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.39004871 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.38543461 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38536885 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38311931 |
| 26 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.30614312 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.29470938 |
| 28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26296730 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.25419207 |
| 30 | Long-term potentiation_Homo sapiens_hsa04720 | 1.21696680 |
| 31 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.18470883 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18042180 |
| 33 | Insulin secretion_Homo sapiens_hsa04911 | 1.17798603 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16265791 |
| 35 | Circadian entrainment_Homo sapiens_hsa04713 | 1.15458232 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.14432700 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.12631505 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.11651166 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11634732 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.10278366 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.09960807 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08993664 |
| 43 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.08674362 |
| 44 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.07204157 |
| 45 | Cocaine addiction_Homo sapiens_hsa05030 | 1.06812192 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05858830 |
| 47 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.03064702 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02818564 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.00635508 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00572467 |
| 51 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99966740 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99085397 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.98893316 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97449309 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.96600603 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95978637 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95415546 |
| 58 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.94860411 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94742170 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.94285499 |
| 61 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93921253 |
| 62 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92828723 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 0.92200356 |
| 64 | Taste transduction_Homo sapiens_hsa04742 | 0.89232166 |
| 65 | Olfactory transduction_Homo sapiens_hsa04740 | 0.89054514 |
| 66 | Axon guidance_Homo sapiens_hsa04360 | 0.88958314 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87977137 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87721507 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86750159 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86447826 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84239887 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83627204 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83390131 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82867160 |
| 75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82721029 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.82514795 |
| 77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.81666687 |
| 78 | Glioma_Homo sapiens_hsa05214 | 0.81400981 |
| 79 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.79405452 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78970829 |
| 81 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77986047 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.76729600 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76421380 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76222656 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | 0.76024443 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75930458 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75431383 |
| 88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75279412 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73919142 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.72999609 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72743716 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72309565 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71884632 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71301179 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71138031 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70684222 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70064602 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.69608303 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.69307078 |
| 100 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.69184726 |
| 101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68893014 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67768457 |
| 103 | Long-term depression_Homo sapiens_hsa04730 | 0.66939552 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66339196 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66175300 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.65919332 |
| 107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64789011 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61100343 |
| 109 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.59267297 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59121700 |
| 111 | Melanogenesis_Homo sapiens_hsa04916 | 0.58809699 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58015870 |
| 113 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57650586 |
| 114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56717521 |
| 115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56284455 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56121515 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55503666 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54778065 |
| 119 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54238475 |
| 120 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53259091 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51889267 |
| 122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51294304 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51214600 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50677133 |
| 125 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50224732 |
| 126 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48790921 |
| 127 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48175339 |
| 128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.48110996 |
| 129 | Alcoholism_Homo sapiens_hsa05034 | 0.47669769 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.47621315 |
| 131 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47283535 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46666681 |
| 133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46513155 |
| 134 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45177070 |
| 135 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43803469 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43492769 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.42816195 |
| 138 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42741746 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42168874 |
| 140 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42153872 |
| 141 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41908379 |
| 142 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38503405 |
| 143 | Gap junction_Homo sapiens_hsa04540 | 0.38178422 |
| 144 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38054531 |
| 145 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36137723 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32869230 |
| 147 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32467504 |
| 148 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.32069544 |
| 149 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31741775 |

